UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

Journal of hepatology, 2018-06, Vol.68 (6), p.1181-1190

2018

Volltextzugriff (PDF)

Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients

The American journal of medicine, 2014-11, Vol.127 (11), p.1118-1125

2014

Volltextzugriff (PDF)

Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities

Autoimmunity reviews, 2020-08, Vol.19 (8), p.102586, Article 102586

2020

Volltextzugriff (PDF)

Authors response: "Heart involvement: a neglected manifestation of haemophagocytic syndrome associated with high mortality"

Journal of critical care, 2024-08, Vol.82, p.154805, Article 154805

Lambotte, Olivier

2024

Volltextzugriff (PDF)

Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies

European journal of cancer (1990), 2017-08, Vol.81, p.135-137

2017

Volltextzugriff (PDF)

Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review

European journal of cancer (1990), 2024-07, Vol.205, p.114075, Article 114075

2024

Volltextzugriff (PDF)

Toxicité des immunothérapies anti-cancéreuses : les pièges à ne pas rater, le rôle de l’interniste

La revue de medecine interne, 2022-08, Vol.43 (8), p.459-461

Lambotte, Olivier

2022

Volltextzugriff (PDF)

Toxicity of cancer immunotherapies: Traps to not miss, the role of the internist

La revue de medecine interne, 2022-08, Vol.43 (8), p.459-461

Lambotte, Olivier

2022

Volltextzugriff (PDF)

Tenofovir-induced osteoporosis fracture in a patient using PrEP: A pitfall for the oncologist

European journal of cancer (1990), 2023-03, Vol.182, p.53-56

2023

Volltextzugriff (PDF)

How to manage patients with corticosteroids in oncology in the era of immunotherapy?

European journal of cancer (1990), 2020-12, Vol.141, p.239-251

2020

Volltextzugriff (PDF)

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

European journal of cancer (1990), 2018-03, Vol.91, p.21-29

2018

Volltextzugriff (PDF)

Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection

Cell metabolism, 2019-03, Vol.29 (3), p.611-626.e5

2019

Volltextzugriff (PDF)

Ocular surface toxicities associated with modern anticancer therapies

Survey of ophthalmology, 2024-03, Vol.69 (2), p.198-210

2024

Volltextzugriff (PDF)

Severe anti-PD1-related meningoencephalomyelitis successfully treated with anti-integrin alpha4 therapy

European journal of cancer (1990), 2021-03, Vol.145, p.230-233

2021

Volltextzugriff (PDF)

The letter responds to comment on: Anti-PD(L)1 immunotherapies in patients with cancer and with pre-existing systemic sclerosis: a post-marketed safety assessment study

European journal of cancer (1990), 2022-04, Vol.165, p.208-209

2022

Volltextzugriff (PDF)

Heart involvement: A neglected manifestation of haemophagocytic syndrome associated with high mortality

Journal of critical care, 2024-04, Vol.80, p.154498, Article 154498

2024

Volltextzugriff (PDF)

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

European journal of cancer (1990), 2017-09, Vol.82, p.34-44

2017

Volltextzugriff (PDF)

Infectious complications in patients treated with immune checkpoint inhibitors

European journal of cancer (1990), 2020-12, Vol.141, p.137-142

2020

Volltextzugriff (PDF)

Immune-related adverse events of cancer immunotherapies targeting kinases

Pharmacology & therapeutics (Oxford), 2022-09, Vol.237, p.108250-108250, Article 108250

2022

Volltextzugriff (PDF)

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1

European journal of cancer (1990), 2018-06, Vol.96, p.91-104

2018

Volltextzugriff (PDF)

Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle

European journal of cancer (1990), 2023-01, Vol.178, p.49-59

2023

Volltextzugriff (PDF)

The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry

European journal of cancer (1990), 2021-11, Vol.158, p.217-224

2021

Volltextzugriff (PDF)

Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

Journal of allergy and clinical immunology, 2024-01, Vol.153 (1), p.256-264

2024

Volltextzugriff (PDF)

Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab

European journal of cancer (1990), 2019-03, Vol.110, p.21-23

2019

Volltextzugriff (PDF)

Long-term impact of immunotherapy on quality of life of surviving patients: A multi-dimensional descriptive clinical study

European journal of cancer (1990), 2021-05, Vol.148, p.211-214

2021

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

ThemaMedical Sciences

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(78)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(77)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(58)
MEDLINE
(45)
Journals@Ovid Full Text
(15)
IngentaConnect Journals
(13)
EZB Electronic Journals Library
(5)
NUS Single-Journal Subscriptions
(5)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients

Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities

Authors response: "Heart involvement: a neglected manifestation of haemophagocytic syndrome associated with high mortality"

Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies

Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review

Toxicité des immunothérapies anti-cancéreuses : les pièges à ne pas rater, le rôle de l’interniste

Toxicity of cancer immunotherapies: Traps to not miss, the role of the internist

Tenofovir-induced osteoporosis fracture in a patient using PrEP: A pitfall for the oncologist

How to manage patients with corticosteroids in oncology in the era of immunotherapy?

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection

Ocular surface toxicities associated with modern anticancer therapies

Severe anti-PD1-related meningoencephalomyelitis successfully treated with anti-integrin alpha4 therapy

The letter responds to comment on: Anti-PD(L)1 immunotherapies in patients with cancer and with pre-existing systemic sclerosis: a post-marketed safety assessment study

Heart involvement: A neglected manifestation of haemophagocytic syndrome associated with high mortality

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

Infectious complications in patients treated with immune checkpoint inhibitors

Immune-related adverse events of cancer immunotherapies targeting kinases

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1

Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle

The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry

Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab

Long-term impact of immunotherapy on quality of life of surviving patients: A multi-dimensional descriptive clinical study

Aktive Filter

Suchergebnisse filtern